Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30081590HIVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS30054655HIVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20002285HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20012659HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20015194HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20029565HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20056003HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20056004HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20027310HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20056163HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TCGA Plot Options
Drug Information
GeneKCNJ6
DrugBank IDDB11633
Drug NameIsavuconazole
Target IDBE0001030
UniProt IDP48051
Regulation Typeinhibitor
PubMed IDs28074556
CitationsKeirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR: QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun;101(6):782-790. doi: 10.1002/cpt.620. Epub 2017 Feb 13.
GroupsApproved; Investigational
Direct ClassificationPhenylpropanes
SMILESC[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Pathways
PharmGKB
ChEMBLCHEMBL409153